Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4‐related diseases: A prospective clinical trial

AIM: The purpose of this study is to evaluate the therapeutic efficacy and safety of iguratimod plus corticosteroid as bridge therapy in the treatment of mild immunoglobulin G4‐related disease (IgG4‐RD). METHODS: Newly diagnosed IgG4‐RD patients, without internal organ involvement were enrolled. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Panpan, Gong, Yiyi, Liu, Zheng, Liu, Yanying, Lin, Wei, Li, Jieqiong, Wang, Mu, Liu, Xiaowei, Fei, Yunyun, Chen, Hua, Peng, Linyi, Li, Jing, Zhou, Jiaxin, Shi, Qun, Zhang, Xuan, Shen, Min, Zeng, Xiaofeng, Zhang, Fengchun, Li, Yongzhe, Zhao, Yan, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772123/
https://www.ncbi.nlm.nih.gov/pubmed/31245907
http://dx.doi.org/10.1111/1756-185X.13633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772123/
https://www.ncbi.nlm.nih.gov/pubmed/31245907
http://dx.doi.org/10.1111/1756-185X.13633

Ejemplares similares